Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
5
Neutral
5
Bullish
4
Bearish
6
Neutral
5
Bullish
35
Bearish
1
Neutral
0
Bullish
31
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Makers Laboratories Limited (MLL) is a pharmaceutical company involved in manufacturing formulations and drug intermediates.
The company has a history of strategic mergers and expansions to increase its production capacity and market presence.
MLL's recent focus includes manufacturing diabetic, hypertensive treatments, and ophthalmic eye drops, indicating a strategy to diversify its product range.
Modernization efforts, including upgrading its liquid injectable unit, suggest ongoing investment in expanding and enhancing production capabilities.
The acquisition of Resonance Specialties Limited highlights MLL's strategic approach towards enhancing its footprint and operational scale.
Pharmaceuticals & Biotechnology
Pharmaceuticals
92 Cr
Low Risk
76.4
34.2
0.4
1.3
173.70
109.00
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: May 25, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Makers Laboratories Ltd (MAKERSL) is currently trading at 156.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Makers Laboratories Limited (MLL) is a pharmaceutical company involved in manufacturing formulations and drug intermediates. The company has a history of strategic mergers and expansions to increase its production capacity and market presence. MLL's recent focus includes manufacturing diabetic, hypertensive treatments, and ophthalmic eye drops, indicating a strategy to diversify its product range. Modernization efforts, including upgrading its liquid injectable unit, suggest ongoing investment in expanding and enhancing production capabilities. The acquisition of Resonance Specialties Limited highlights MLL's strategic approach towards enhancing its footprint and operational scale.
Over the past 52 weeks, Makers Laboratories Ltd has traded between a low of ₹109.00 and a high of ₹173.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Makers Laboratories Ltd has a market capitalization of approximately 92.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Makers Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 76.44 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 92.49 Cr, Makers Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Makers Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Makers Laboratories Ltd is 76.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
116.00 | 105 Cr | 19.56 | 2.80 | 0.00 | 0.00 | 0.00 | 0.00 | ||
7.71 | 97 Cr | -183.89 | 1.45 | 0.00 | -0.57 | 1.54 | -0.43 | ||
770.00 | 96 Cr | 20.31 | 1.72 | 0.44 | 8.81 | 11.49 | 6.38 | ||
149.00 | 92 Cr | 76.44 | 1.31 | 0.00 | -0.03 | 8.67 | 3.76 | ||
17.74 | 84 Cr | -4.65 | 0.00 | 0.00 | -22.95 | -11.16 | -9.61 | ||
56.03 | 82 Cr | 110.42 | 3.06 | 0.00 | 2.42 | 3.29 | 2.78 | ||
125.55 | 78 Cr | 28.21 | 3.31 | 0.00 | 12.56 | 15.10 | 6.85 | ||
| Median: 7 Co. | — | 116.00 | 92 Cr | 20.31 | 1.72 | 0.00 | 0.00 | 3.29 | 2.78 |
